During dataset creation, some inflammatory markers were not routinely measured, making it difficult to distinguish between true iron overload (e.g., hemochromatosis) from inflammation-driven ferritin elevations due to limited aetiologic coding and inflammatory biomarkers; future work incorporating CRP, hepcidin, and sTfR is indeed warranted. This evidence concerns the gene TFRC and Tangier disease.